Alphatec Spine to Host Technology Day on June 6, 2013 in New York City

Venue: Convene Conference Center (730 Third Avenue) From 8:30 AM to 11:30 AM

        Print
| Source: Alphatec Holdings, Inc.

CARLSBAD, Calif., May 29, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets physician-inspired solutions for patients with spinal disorders, announced today that the Company will conduct a Technology Day for investors and analysts on Thursday, June 6, 2013 from 8:30 AM to 11:30 AM Eastern Time at the Convene Conference Center (formerly Sentry Centers), which is located at 730 Third Avenue in NYC.

The agenda will include presentations from Alphatec's senior management and select spine surgeons, followed by a question and answer period and product demonstrations. To register for this event, please RSVP to investor relations prior to May 31, 2013. Seating is limited.

AGENDA:

8:30 AM – Registration

9:00 AM – Management presentations

9:30 AM – Technology presentations

Antonio Castellvi, MD: ILLICO® ML

Celeste Abjornson, PhD: Alphatec NEXoss®

Jeffrey Bash, MD and Joseph Aferzon, MD:  Alphatec Solus®

Boyle Cheng PhD:  BridgePoint® and Alphatec Solus Biomechanical Study             

10:30 AM – Q&A / Surgeon Panel

10:45 AM – Product Demonstrations

Biologics

Cervical/Interbody – Pegasus™ ACI, Alphatec Solus

MIS – ILLICO ML

Thoracolumbar – Zodiac® DVR

The presentations made by the Company's management at the Alphatec Spine Technology Day will be webcast live and accessible through the Company's investor relations website at www.alphatecspine.com. An archived edition of the presentation will be available later that day and will be available for at least 30 days afterwards.

About Alphatec Spine

Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a medical device company that designs, develops, manufactures and markets products and solutions for the treatment of spinal disorders associated with trauma, congenital deformities, disease and degeneration. The Company's mission is to combine innovative, surgeon-inspired solutions that will help improve outcomes and patient's quality of life, with world-class customer service. To achieve its mission, the Company strives to commercialize new and innovative devices and technologies, including improved minimally invasive surgery (MIS) products and techniques and integrated biologics solutions. The Company markets its products and the products of its affiliates in the U.S. and in over 50 countries internationally via a direct sales force and independent distributors. Additional information can be found at www.alphatecspine.com.

Investor/Media Contact:

Mark Francois
Senior Director, Investor Relations
Alphatec Spine, Inc.
(760) 494-6610